LEADER 01745oam  2200493   450 
001 9910717094703321
005 20220125073520.0
035   $a(CKB)5470000002527255
035   $a(OCoLC)1277198926
035   $a(EXLCZ)995470000002527255
100   $a20211019d2021      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aRare diseases $ealthough limited, available evidence suggests medical and other costs can be substantial : report to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2021.
215   $a1 online resource (ii, 103 pages) : b (color illustrations)
300   $a"October 2021"--Cover.
300   $aJohn E. Dicken, Director, Health Care"--Page 42.
320   $aIncludes bibliographical references.
517   $aRare diseases 
606   $aRare diseases$xDiagnosis$zUnited States
606   $aRare diseases$zUnited States$xCosts
606   $aRare diseases$xTreatment$zUnited States
606   $aRare diseases$xTreatment$zUnited States$xCosts
606   $aDiagnostic errors$xRisk assessment$zUnited States
606   $aDiagnostic errors$zUnited States$xCosts
615  0$aRare diseases$xDiagnosis
615  0$aRare diseases$xCosts.
615  0$aRare diseases$xTreatment
615  0$aRare diseases$xTreatment$xCosts.
615  0$aDiagnostic errors$xRisk assessment
615  0$aDiagnostic errors$xCosts.
702   $aDicken$b John E.
801  0$bDID
801  1$bDID
801  2$bSTF
801  2$bGPO
906   $aBOOK
912   $a9910717094703321
996   $aRare Diseases$91764285
997   $aUNINA